Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (260)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mutation
21
2022
1294
1.790
 Why?
Multiple Myeloma
38
2023
2954
1.740
 Why?
High-Throughput Nucleotide Sequencing
5
2021
170
1.050
 Why?
Translocation, Genetic
14
2021
264
1.010
 Why?
Oncogenes
2
2018
57
0.760
 Why?
Biliary Tract Neoplasms
1
2018
9
0.610
 Why?
Gene Expression Profiling
14
2022
1037
0.610
 Why?
Cholangiocarcinoma
1
2018
26
0.610
 Why?
Genomics
8
2022
285
0.560
 Why?
Proto-Oncogene Proteins B-raf
3
2022
79
0.540
 Why?
Gene Expression Regulation, Neoplastic
11
2022
828
0.530
 Why?
Prognosis
15
2021
1954
0.440
 Why?
Brain Neoplasms
3
2023
288
0.410
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
990
0.400
 Why?
Gene Dosage
5
2020
78
0.400
 Why?
Genetic Predisposition to Disease
5
2018
509
0.390
 Why?
Plasma Cells
4
2021
223
0.390
 Why?
Genome, Human
4
2021
111
0.370
 Why?
Evolution, Molecular
2
2021
99
0.360
 Why?
Liver Neoplasms
3
2022
328
0.360
 Why?
Humans
51
2023
50208
0.360
 Why?
DNA Mutational Analysis
7
2020
176
0.350
 Why?
Thalidomide
5
2019
377
0.340
 Why?
DNA Copy Number Variations
4
2021
110
0.330
 Why?
In Situ Hybridization, Fluorescence
11
2023
259
0.330
 Why?
Software
2
2021
271
0.310
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
115
0.310
 Why?
Neoplasm Recurrence, Local
3
2021
613
0.290
 Why?
Carcinoma, Hepatocellular
2
2022
193
0.280
 Why?
Chromosome Aberrations
6
2022
297
0.280
 Why?
Polymorphism, Single Nucleotide
3
2018
485
0.280
 Why?
Epigenesis, Genetic
4
2018
378
0.260
 Why?
Clonal Evolution
2
2019
56
0.260
 Why?
Chromosomes, Human, Pair 1
2
2019
93
0.260
 Why?
Immunoglobulin Heavy Chains
3
2014
41
0.250
 Why?
Neoplasm Proteins
3
2017
324
0.250
 Why?
Disease Progression
8
2021
831
0.240
 Why?
Gene Regulatory Networks
2
2022
107
0.230
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
23
0.220
 Why?
Polycomb Repressive Complex 2
2
2021
47
0.220
 Why?
Male
25
2021
25399
0.210
 Why?
Chromosomes, Human, Pair 14
5
2014
75
0.210
 Why?
Female
26
2021
26635
0.210
 Why?
Central Nervous System Neoplasms
1
2023
64
0.210
 Why?
Exome
4
2017
46
0.210
 Why?
STAT2 Transcription Factor
1
2021
7
0.200
 Why?
Germ-Line Mutation
2
2021
61
0.200
 Why?
STAT1 Transcription Factor
1
2021
26
0.200
 Why?
Hematologic Neoplasms
1
2023
99
0.200
 Why?
Middle Aged
17
2021
12206
0.200
 Why?
Li-Fraumeni Syndrome
1
2021
13
0.200
 Why?
Aged
15
2021
9405
0.200
 Why?
Genome-Wide Association Study
3
2018
166
0.200
 Why?
Japan
2
2018
26
0.190
 Why?
Gene Frequency
2
2017
94
0.180
 Why?
Aged, 80 and over
9
2021
3154
0.180
 Why?
Ecosystem
1
2021
64
0.180
 Why?
Cell Cycle
1
2021
232
0.180
 Why?
Neoplasms
2
2020
1249
0.180
 Why?
Glioblastoma
1
2021
93
0.180
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.180
 Why?
Leukemia, Plasma Cell
1
2020
33
0.180
 Why?
DNA Methylation
3
2016
550
0.170
 Why?
Chromosomal Instability
1
2019
16
0.170
 Why?
Genes, myc
1
2019
41
0.160
 Why?
Chromosomes, Human, Pair 4
3
2014
31
0.160
 Why?
Diploidy
2
2017
26
0.160
 Why?
Chromosomes, Human, Pair 11
3
2014
54
0.160
 Why?
Cell Survival
2
2018
602
0.160
 Why?
INDEL Mutation
1
2018
4
0.150
 Why?
Adult
13
2021
13324
0.150
 Why?
Genes, Tumor Suppressor
2
2021
73
0.150
 Why?
Mutagenesis
1
2018
60
0.150
 Why?
Italy
1
2018
26
0.150
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
13
0.150
 Why?
Transcriptional Elongation Factors
1
2017
18
0.150
 Why?
Chromosomes, Human, Pair 5
1
2017
17
0.150
 Why?
Histone-Lysine N-Methyltransferase
2
2016
55
0.150
 Why?
Transcriptome
4
2021
320
0.150
 Why?
Enhancer Elements, Genetic
1
2017
61
0.150
 Why?
Reproducibility of Results
1
2021
1185
0.140
 Why?
Chromosomes, Human
1
2017
41
0.140
 Why?
Melanoma
1
2020
290
0.140
 Why?
Hepatocytes
1
2018
182
0.140
 Why?
Immunologic Factors
1
2017
114
0.140
 Why?
B-Lymphocytes
2
2016
170
0.140
 Why?
Neoplasms, Multiple Primary
1
2016
44
0.140
 Why?
Neoplasm Metastasis
1
2016
236
0.130
 Why?
Melphalan
2
2013
174
0.130
 Why?
Oligodendroglioma
1
2015
6
0.130
 Why?
Sequence Analysis, DNA
2
2016
238
0.130
 Why?
Endoribonucleases
1
2015
15
0.130
 Why?
ras Proteins
1
2015
64
0.130
 Why?
Survival Rate
4
2020
901
0.120
 Why?
Skin Neoplasms
1
2020
492
0.120
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
41
0.120
 Why?
Endoplasmic Reticulum Stress
1
2015
43
0.120
 Why?
Survival Analysis
5
2015
666
0.120
 Why?
SMN Complex Proteins
1
2014
4
0.120
 Why?
RNA Processing, Post-Transcriptional
1
2014
24
0.120
 Why?
Signal Transduction
5
2022
1622
0.120
 Why?
Mutation Rate
3
2021
36
0.120
 Why?
Cyclin D
1
2013
18
0.120
 Why?
Chromosome Deletion
2
2011
140
0.120
 Why?
Transcription Factors
2
2015
564
0.110
 Why?
Kaplan-Meier Estimate
4
2018
465
0.110
 Why?
Genes, erbB-1
1
2013
8
0.110
 Why?
RNA, Neoplasm
1
2013
45
0.110
 Why?
Nerve Tissue Proteins
1
2015
193
0.110
 Why?
Cell Line, Tumor
4
2022
1416
0.110
 Why?
Chromosome Breakage
1
2013
16
0.110
 Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.110
 Why?
Germinal Center
1
2013
23
0.110
 Why?
Repressor Proteins
1
2014
153
0.110
 Why?
RNA Splicing
3
2021
37
0.110
 Why?
Genetic Heterogeneity
1
2012
18
0.100
 Why?
Cell Transformation, Neoplastic
1
2013
179
0.100
 Why?
DNA-Binding Proteins
1
2015
428
0.100
 Why?
Acetyltransferases
1
2011
19
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
27
0.100
 Why?
RNA, Messenger
1
2015
1108
0.100
 Why?
Chromosomes, Human, Pair 17
1
2011
36
0.100
 Why?
Antineoplastic Agents
3
2018
1186
0.100
 Why?
DNA, Neoplasm
3
2018
147
0.100
 Why?
Cell Proliferation
3
2022
1013
0.100
 Why?
Multivariate Analysis
3
2021
581
0.090
 Why?
TOR Serine-Threonine Kinases
1
2010
77
0.090
 Why?
Tumor Suppressor Protein p53
1
2011
203
0.090
 Why?
Phenotype
3
2022
733
0.090
 Why?
Remission Induction
2
2021
207
0.090
 Why?
Clone Cells
2
2021
78
0.090
 Why?
MicroRNAs
1
2013
355
0.080
 Why?
DNA
1
2012
541
0.080
 Why?
Alleles
2
2021
251
0.080
 Why?
Transcriptional Activation
2
2021
121
0.080
 Why?
Spliceosomes
2
2021
10
0.080
 Why?
Follow-Up Studies
3
2020
2190
0.070
 Why?
Genomic Instability
2
2018
93
0.070
 Why?
Epigenomics
2
2017
68
0.070
 Why?
Risk Factors
3
2021
3629
0.070
 Why?
Loss of Heterozygosity
2
2018
77
0.060
 Why?
Disease-Free Survival
2
2019
454
0.060
 Why?
Treatment Outcome
4
2019
5155
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.060
 Why?
Protein Binding
2
2017
665
0.060
 Why?
Liver
2
2022
1116
0.060
 Why?
Genotype
2
2017
534
0.060
 Why?
Dexamethasone
2
2019
430
0.050
 Why?
Histones
2
2016
313
0.050
 Why?
Proportional Hazards Models
2
2015
410
0.050
 Why?
Janus Kinase 1
1
2021
17
0.050
 Why?
Janus Kinase 2
1
2021
26
0.050
 Why?
Nitriles
1
2021
54
0.050
 Why?
Gene Rearrangement
1
2022
74
0.050
 Why?
Organoids
1
2021
40
0.050
 Why?
Syndecan-1
1
2021
72
0.050
 Why?
Microarray Analysis
2
2012
73
0.050
 Why?
Biomarkers, Pharmacological
2
2011
25
0.050
 Why?
Chromosome Mapping
2
2011
156
0.050
 Why?
Polymerase Chain Reaction
2
2013
454
0.050
 Why?
Pyrazoles
1
2021
114
0.050
 Why?
Cell Movement
1
2022
249
0.050
 Why?
Cell Line
2
2015
1021
0.050
 Why?
Alternative Splicing
1
2021
56
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
 Why?
Gene Expression Regulation, Leukemic
1
2020
33
0.050
 Why?
Phosphoproteins
1
2021
108
0.040
 Why?
Pyrimidines
1
2021
193
0.040
 Why?
Gene Expression
2
2013
609
0.040
 Why?
Lymphoma, Follicular
1
2020
27
0.040
 Why?
Prospective Studies
2
2016
2379
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Recurrence
1
2021
662
0.040
 Why?
Young Adult
2
2021
3981
0.040
 Why?
Maintenance Chemotherapy
1
2019
49
0.040
 Why?
Syndrome
1
2019
238
0.040
 Why?
Transcription Elongation, Genetic
1
2017
2
0.040
 Why?
Physical Chromosome Mapping
1
2017
8
0.040
 Why?
Genetic Drift
1
2017
3
0.040
 Why?
Gene Knockdown Techniques
1
2018
106
0.040
 Why?
Caspases
1
2018
104
0.040
 Why?
Unfolded Protein Response
1
2017
32
0.040
 Why?
Genetic Loci
1
2017
49
0.040
 Why?
Xenograft Model Antitumor Assays
1
2018
212
0.040
 Why?
Molecular Targeted Therapy
1
2018
121
0.040
 Why?
Mitosis
1
2017
93
0.040
 Why?
Genetic Association Studies
1
2017
116
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Virus Integration
1
2016
8
0.030
 Why?
Algorithms
1
2020
618
0.030
 Why?
Comparative Genomic Hybridization
1
2016
47
0.030
 Why?
Risk
1
2017
324
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
40
0.030
 Why?
Computational Biology
1
2018
216
0.030
 Why?
Nuclear Proteins
1
2017
243
0.030
 Why?
Immunosuppressive Agents
1
2017
222
0.030
 Why?
Tumor Microenvironment
1
2017
233
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
17
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Cytidine Deaminase
1
2015
12
0.030
 Why?
Antibodies, Monoclonal
1
2019
460
0.030
 Why?
RNA Stability
1
2015
24
0.030
 Why?
Patient Selection
1
2016
253
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
50
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
19
0.030
 Why?
Amino Acid Sequence
1
2016
586
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
10
0.030
 Why?
Cytogenetic Analysis
1
2014
82
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Flow Cytometry
1
2017
476
0.030
 Why?
Time Factors
1
2021
2922
0.030
 Why?
Single-Cell Analysis
1
2014
61
0.030
 Why?
Introns
1
2014
48
0.030
 Why?
Methylation
1
2014
123
0.030
 Why?
Protein Isoforms
1
2014
119
0.030
 Why?
Down-Regulation
1
2015
349
0.030
 Why?
Base Sequence
1
2015
644
0.030
 Why?
High-Throughput Screening Assays
1
2013
36
0.030
 Why?
Protein Structure, Tertiary
1
2014
253
0.030
 Why?
HeLa Cells
1
2014
260
0.030
 Why?
Molecular Sequence Data
1
2015
793
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
29
0.030
 Why?
Karyotyping
1
2013
83
0.030
 Why?
Azacitidine
1
2013
34
0.030
 Why?
Transforming Growth Factor beta1
1
2013
60
0.030
 Why?
Early Detection of Cancer
1
2014
167
0.030
 Why?
Mass Spectrometry
1
2014
301
0.030
 Why?
Homologous Recombination
1
2013
41
0.030
 Why?
Disease Models, Animal
1
2018
1458
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Tumor Suppressor Proteins
1
2013
128
0.030
 Why?
Apoptosis
1
2018
1112
0.030
 Why?
Gene Library
1
2012
43
0.030
 Why?
Laboratories
1
2012
21
0.030
 Why?
Hemizygote
1
2011
6
0.020
 Why?
Predictive Value of Tests
1
2014
905
0.020
 Why?
Drug Resistance, Neoplasm
1
2013
314
0.020
 Why?
Animals
2
2018
13246
0.020
 Why?
Bone Marrow
1
2013
363
0.020
 Why?
Breast Neoplasms
1
2020
1179
0.020
 Why?
Vincristine
1
2010
88
0.020
 Why?
Prednisolone
1
2010
55
0.020
 Why?
Adolescent
1
2021
6390
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
411
0.020
 Why?
Cluster Analysis
1
2010
235
0.020
 Why?
Precancerous Conditions
1
2010
83
0.020
 Why?
Cyclophosphamide
1
2010
166
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
143
0.020
 Why?
Clinical Trials as Topic
1
2012
466
0.020
 Why?
Stem Cell Transplantation
1
2010
182
0.020
 Why?
Child
1
2021
6851
0.020
 Why?
Sex Factors
1
2011
697
0.020
 Why?
Models, Biological
1
2012
723
0.020
 Why?
Doxorubicin
1
2010
239
0.020
 Why?
Up-Regulation
1
2010
453
0.020
 Why?
Risk Assessment
1
2013
1262
0.020
 Why?
Prevalence
1
2011
951
0.020
 Why?
Mice
1
2018
5759
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (260) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department